4D Molecular Therapeutics, Inc.
FDMT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650648
In the last 90 days, 4D Molecular Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 157 institutions reported holding it in 13F filings for Q2 2026, worth $771.2M in total; no superinvestor holds it.
Holders of 5% or more of FDMT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of 4D Molecular Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G/A | 10.30%5.25M shares | +2.20 ppfrom 8.10% | Feb 11, 20227 filings | Apr 7, 2026 | SEC |
| Biotechnology Value Fund L P | 13G/A | 9.99%5.35M shares | 0.00 ppfrom 9.99% | Jul 6, 20218 filings | May 15, 2026 | SEC |
| Ra Capital Management, L.P. | 13G/A | 9.90%5.11M shares | 0.00 ppfrom 9.90% | Jun 5, 20237 filings | May 15, 2026 | SEC |
| Goldman Sachs Group Inc | 13G/A | 7.50%4.29M shares | −2.10 ppfrom 9.60% | Nov 6, 20243 filings | Feb 9, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 6.60%3.06M shares | −1.20 ppfrom 7.80% | Oct 21, 20245 filings | Oct 17, 2025 | SEC |
| Novo Holdings A/S | 13G/A | 6.40%3.65M shares | −0.40 ppfrom 6.80% | Oct 20, 20252 filings | Feb 17, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
66 Schedule 13D and 13G filings on 4D Molecular Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 20266:16 AM ET | State Street Corp | 13G | 4.50%2.47M shares | −0.80 ppfrom 5.30%Below 5% | Sep 30, 2026 | SEC |
| May 15, 20264:30 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%5.11M shares | 0.00 ppfrom 9.90% | Mar 31, 2026 | SEC |
| May 15, 20264:08 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%5.35M shares | 0.00 ppfrom 9.99% | Mar 31, 2026 | SEC |
| May 12, 20269:42 AM ET | State Street Corp | 13G | 5.30%2.71M shares | New | Mar 31, 2026 | SEC |
| Apr 7, 20263:48 PM ET | Janus Henderson Group PLC | 13G/A | 10.30%5.25M shares | +2.20 ppfrom 8.10% | Mar 31, 2026 | SEC |
| Mar 26, 20269:02 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 17, 20266:55 PM ET | Novo Holdings A/S | 13G/A | 6.40%3.65M shares | −0.40 ppfrom 6.80% | Dec 31, 2025 | SEC |
| Feb 17, 20264:15 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%5.71M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Feb 17, 20264:12 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%5.85M shares | 0.00 ppfrom 9.99% | Dec 31, 2025 | SEC |
| Feb 17, 202612:42 PM ET | Janus Henderson Group PLC | 13G | 8.10%4.64M shares | +3.20 ppfrom 4.90% | Dec 31, 2025 | SEC |
| Feb 9, 20264:05 PM ET | Goldman Sachs Group Incand 1 other | 13G/A | 7.50%4.29M shares | −2.10 ppfrom 9.60% | Dec 31, 2025 | SEC |
| Oct 20, 20255:12 PM ET | Novo Holdings A/S | 13G | 6.80%3.17M shares | New | Oct 13, 2025 | SEC |
| Oct 17, 20256:13 PM ET | BlackRock, Inc. | 13G/A | 6.60%3.06M shares | −1.20 ppfrom 7.80% | Sep 30, 2025 | SEC |
| May 15, 20255:44 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 1.50%677.6K shares | −4.90 ppfrom 6.40%Below 5% | Mar 31, 2025 | SEC |
| May 15, 20254:29 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%4.63M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 7.80%3.62M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20256:30 PM ET | Ra Capital Management, L.P.and 3 others | 13G/A | 9.90%4.56M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20256:09 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13G/A | 6.40%2.95M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:20 PM ET | Biotechnology Value Fund L Pand 9 others | 13G/A | 9.99%4.83M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 202511:34 AM ET | Janus Henderson Group PLC | 13G/A | 4.90%2.25M shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20258:40 AM ET | Deep Track Capital, LPand 2 others | 13G/A | 1.32%609.9K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 10, 20255:28 PM ET | Goldman Sachs Group Incand 1 other | 13G/A | 9.60%4.42M shares | – | Dec 31, 2024 | SEC |
| Dec 6, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 15, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Nov 13, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Nov 12, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Nov 6, 2024 | Goldman Sachs Group Inc | 13GOld format | – | New | – | SEC |
| Nov 4, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Oct 21, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Kirn David | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20244:59 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2024 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2024 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Jun 5, 2023 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| May 15, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13GOld format | – | New | – | SEC |
| Feb 14, 2023 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Kirn David | 13G/AOld format | – | – | – | SEC |
| Jan 31, 20231:58 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jun 21, 2022 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
30 notices from officers, directors and other affiliates planning to sell 4D Molecular Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Oct 5, 20266:23 PM ET | David KirnOfficer | 58.3K | $753.7K | Oct 5, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Sep 14, 20266:00 PM ET | David KirnOfficer | 58.3K | $802.7K | Sep 14, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Aug 19, 20266:28 PM ET | David KirnOfficer | 69.1K | $1.16M | Aug 19, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Aug 17, 20264:46 PM ET | Scott BizilyOfficer | 6.54K | $79.7K | Aug 17, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 13, 20264:33 PM ET | Scott BizilyOfficer | 1.64K | $19.4K | Aug 13, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Aug 4, 20266:08 PM ET | David KirnOfficer | 26.8K | $275.4K | Aug 4, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Aug 3, 20265:29 PM ET | David KirnOfficer | 12.4K | $125.3K | Aug 3, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jul 10, 20264:54 PM ET | David KirnOfficer | 15.7K | $193.6K | Jul 10, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jul 9, 20265:21 PM ET | David KirnOfficer | 42.6K | $549.2K | Jul 9, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jun 30, 20264:38 PM ET | Scott BizilyOfficer | 6.57K | $84.6K | Jun 30, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 23, 20264:29 PM ET | Scott BizilyOfficer | 9.81K | $102.2K | Jun 23, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 22, 20265:58 PM ET | David KirnOfficer | 114.7K | $1.20M | Jun 22, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jun 1, 20265:40 PM ET | David KirnOfficer | 1.92K | $18.7K | Jun 1, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Dec 16, 20254:33 PM ET | Scott BizilyOfficer | 1.64K | $17.9K | Dec 16, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 17, 20254:33 PM ET | Scott BizilyOfficer | 1.64K | $17.6K | Nov 17, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 24, 20254:26 PM ET | Scott BizilyOfficer | 1.82K | $18.2K | Oct 24, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Sep 23, 20254:20 PM ET | Scott BizilyOfficer | 7.31K | $54.1K | Sep 23, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 10, 20245:17 PM ET | David KirnOfficer | 12.9K | $299.9K | Jul 10, 202410b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jul 1, 20244:43 PM ET | Scott BizilyOfficer | 9.50K | $199.4K | Jul 1, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 25, 20244:44 PM ETAmended | David KirnOfficer | 12.9K | $300.6K | Jun 24, 202410b5-1 | Goldman Sachs & Co. LLC | SEC |
| Apr 1, 20244:29 PM ET | Scott BizilyOfficer | 13.4K | $427.0K | Apr 1, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 8, 20244:50 PM ET | David KirnOfficer | 92.0K | $2.47M | Feb 8, 202410b5-1 | Goldman Sachs & Co. LLC | SEC |
| Feb 8, 20244:22 PM ET | Scott BizilyOfficer | 17.7K | $500.9K | Feb 8, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 23, 20244:50 PM ET | David KirnOfficer | 5.70K | $105.1K | Jan 23, 202410b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jan 5, 20244:49 PM ET | David KirnOfficer | 28.2K | $553.2K | Jan 5, 202410b5-1 | Goldman Sachs & Co. LLC | SEC |
Showing the latest 25. See the FDMT notices from the last 12 months